Psykey, Inc. (OTCMKTS:CEOS) Sees Large Drop in Short Interest

Psykey, Inc. (OTCMKTS:CEOS) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 2,400 shares, a decline of 98.4% from the November 30th total of 149,000 shares. Based on an average daily volume of 2,072,800 shares, the short-interest ratio is currently 0.0 days.

Psykey Stock Performance

Shares of OTCMKTS CEOS traded up $0.00 during trading hours on Thursday, reaching $0.03. The stock had a trading volume of 1,320,150 shares, compared to its average volume of 609,697. Psykey has a twelve month low of $0.01 and a twelve month high of $0.05. The business’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.02.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.